| ²é¿´: 714 | »Ø¸´: 1 | ||||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||||
zxľľϦгæ (³õÈëÎÄ̳)
|
[ÇóÖú]
Altered compensatory cytokine signaling underlies
|
|||
| The receptor Flt3 and its ligand Flt3L are both critical for dendritic cell (DC) development, but DC deficiency is more severe in Flt3l−/− mice than in Flt3−/− mice. This has led to speculation that Flt3L binds to another receptor that also supports DC development. However, we found that Flt3L administration does not generate DCs in Flt3−/− mice, arguing against a second receptor. Instead, Flt3−/− DC progenitors matured in response to macrophage colony¨Cstimulating factor (M-CSF) or stem cell factor, and deletion of Csf1r in Flt3−/− mice further reduced DC development, indicating that these cytokines could compensate for Flt3. Surprisingly, Flt3−/− DC progenitors displayed enhanced M-CSF signaling, suggesting that loss of Flt3 increased responsiveness to other cytokines. In agreement, deletion of Flt3 in Flt3l−/− mice paradoxically rescued their severe DC deficiency. Thus, multiple cytokines can support DC development, and the discrepancy between Flt3−/− and Flt3l−/− mice results from the increased sensitivity of Flt3−/− progenitors to these cytokines. |
» ²ÂÄãϲ»¶
±¾9Ò»Ö¾Ô¸2 0854µÍ·Öר˶286Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
070300»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
085701Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ7È˻ظ´
²ÄÁÏרҵ383Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ²ÄÁϹ¤³Ì085601£¬Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤085600£¬Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬321·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ÇóÉúÎïѧµ÷¼Á
ÒѾÓÐ11È˻ظ´
frozenfox7
ר¼Ò¹ËÎÊ (ÕýʽдÊÖ)
-

ר¼Ò¾Ñé: +56 - ·ÒëEPI: 60
- Ó¦Öú: 31 (СѧÉú)
- ½ð±Ò: 4247.5
- ºì»¨: 29
- Ìû×Ó: 478
- ÔÚÏß: 119.1Сʱ
- ³æºÅ: 8497466
- ×¢²á: 2018-04-10
- ÐÔ±ð: MM
- רҵ: »ùÒò×éѧ
- ¹ÜϽ: רҵÍâÓï
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
°®ÓëÓêÏÂ: ½ð±Ò+1 2018-10-10 21:10:13
zxľľϦ(fjtony163´ú·¢): ½ð±Ò+5, ´ú·¢ 2018-11-18 05:31:35
fjtony163: ·ÒëEPI+1, ´ú·¢ 2018-11-18 05:31:39
°®ÓëÓêÏÂ: ½ð±Ò+1 2018-10-10 21:10:13
zxľľϦ(fjtony163´ú·¢): ½ð±Ò+5, ´ú·¢ 2018-11-18 05:31:35
fjtony163: ·ÒëEPI+1, ´ú·¢ 2018-11-18 05:31:39
|
ÏÈÃ÷È·Á½ÕߵĹØÏµ£º Flt3lÊÇFit3µÄÅäÌ壬ËùÒÔÊÇFit3 Ligand Fit3ÊÇËüµÄreceptor¡£ Æä´Î£¬¸ù¾ÝÕâÆªÎÄÕµÄÕªÒª¼òµ¥µÄ½²£¬Fit3L ºÍFit3 µÄÏ໥×÷Óñ»ÈÏΪÊÇDC²úÉúµÄ¹Ø¼ü¡£ µÚÈý£¬×÷Õß·¢ÏÖÅäÌåË«ÇÃСÊó ±È ÊÜÌåË«ÇÃСÊóµÄ DCʧµ÷¸ü¼ÓÑÏÖØ£¬¸Õ¿ªÊ¼ÒÔΪÊÇFit3L ºÜ¿ÉÄÜ´æÔÚ³ýÁËFit3Ö®Í⻹ÓеڶþÖÖÊÜÌ壬¶øfit3Óë¼ÙÏëÊÜÌåµÄÏ໥×÷Óã¬Ò²²ÎÓëDCÉú³ÉµÄµ÷¿Ø£¬Òò´ËFit3L Ë«ÇòúÉúµÄ½á¹û±ÈFit3ÊÜÌåË«ÇÃÒªÑÏÖØ¡£ µÚËÄ£¬½á¹û·¢ÏÖ²»ÊÇÄÇô»ØÊ£¬Èç¹ûÔÚÊÜÌåË«ÇÃСÊóÉϸøÓèÅäÌåÖÎÁÆ£¬·¢ÏÖ»¹ÊÇÎÞ·¨Éú³ÉDC£¬Õâ¾ÍÅųýÁ˵ڶþÖÖÊÜÌåµÄ¼Ù˵¡£ µÚÎ壬·¢ÏÖÖ®ËùÒÔµ¼ÖÂFit3ÅäÌåË«Çà ±È ÊÜÌåË«Çà ÑÏÖØµÄÔÒò£¬ÊÇÒòΪÊÜÌåFit3Èç¹û±»Çóý£¬»áÓÐÆäËûϸ°ûÒò×ÓÐźÅͨ·(±ÈÈçM-CSF)³ÊÏÖ´ú³¥ÐÔµÄÔö¼ÓÀ´ÃÖ²¹DCÉú³É£¬Òò´Ë£¬ÊÜÌåË«ÇòúÉúµÄÖ¢×´¾ÍÏà¶Ô¼õÇáÁË¡£ ·´¹ýÀ´¿´ÌâÄ¿£¬Æäʵ¾ÍÊÇÒòΪÕâЩϸ°ûÒò×ӵĸı䣬µ¼ÖÂÅäÌåÓëÊÜÌåÁ½ÖÖË«ÇÃСÊó´æÔÚÁ˲îÒì¡£ |
2Â¥2018-10-08 22:35:04














»Ø¸´´ËÂ¥